Disease/Infection News

RSS

Researchers test effectiveness of commercially available mosquito repellents

Researchers at New Mexico State University tested 10 commercially available products for their effectiveness at repelling mosquitoes, and the results were published in the Journal of Insect Science.

29 Oct 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover and develop messenger RNA (mRNA) therapeutics to certain rare disease targets using Arcturus' UNA Oligomer chemistry and LUNAR nanoparticle delivery platform.

29 Oct 2015

New studies raise important questions about impact of statin therapy on effectiveness of flu vaccines

A new pair of studies suggests that statins, drugs widely used to reduce cholesterol, may have a detrimental effect on the immune response to influenza vaccine and the vaccine's effectiveness at preventing serious illness in older adults. Published in The Journal of Infectious Diseases, the findings, if confirmed by additional research, may have implications for flu vaccine recommendations, guidelines for statin use around the time of vaccination, and future vaccine clinical trials in seniors.

29 Oct 2015

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization’s Global Tuberculosis Report 2015, which was released today in Washington, DC.

29 Oct 2015

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

More than 3.7 billion people under the age of 50 – or 67% of the population – are infected with herpes simplex virus type 1 (HSV-1), according to the World Health Organization’s first global estimates of HSV-1 infection published today in the journal PLOS ONE.

29 Oct 2015

UAB researcher awarded NIH grant to study pathogenesis of thrombotic microangiopathy

University of Alabama at Birmingham researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA. In simple terms, this means looking for factors that cause or aid the onset of extensive microscopic clots in small blood vessels throughout the body. Though tiny, these spots can damage kidneys, heart and brain, and they can cause death.

29 Oct 2015

Vasculitis Foundation named winner in Nonprofit Connect 2015 Philly Awards

The Vasculitis Foundation has been chosen as a winner in the Nonprofit Connect 2015 Philly Awards. Nonprofit Connect holds this competition to recognize outstanding achievements in nonprofit marketing and communications.

29 Oct 2015

Scientists identify key groups of bacteria responsible for majority of meningococcal cases in England, Wales

Scientists at Oxford University have identified the key groups of bacteria responsible for the majority of meningococcal disease cases in England and Wales over the past 20 years.

29 Oct 2015

New paper device could rapidly and inexpensively assess hepatitis B, male infertility

Scientists have developed a new paper device that analyzes DNA and could rapidly and inexpensively assess disparate conditions including hepatitis B and male infertility, which together affect millions of people around the world. The test, reported in the Journal of the American Chemical Society, could be of particular help diagnosing people in low-income areas.

29 Oct 2015

Researchers report new way to help improve vaccines using molecules that direct the immune system

As the days get colder and shorter, we carve jack-o-lanterns and drink pumpkin spice lattes. But one fall tradition can actually keep you healthy: getting your flu shot. Like all vaccines, the flu shot trains the immune system to fend off infection, but some need help to produce the full effect.

29 Oct 2015

New broad-spectrum antibiotic can kill bacteria by punching holes in their membranes

Bacteria have many methods of adapting to resist antibiotics, but a new class of spiral polypeptides developed at the University of Illinois targets one thing no bacterium can live without: an outer membrane.

29 Oct 2015

Hiroshima University researchers report promising new avenue for treating hepatitis B

A promising new avenue for treating hepatitis B has been reported by researchers at Hiroshima University who have developed a new animal model of the disease.

28 Oct 2015

Researchers uncover genes that can suppress HCV infection within the liver

University of Adelaide researchers have uncovered the role played by a family of genes, which can suppress hepatitis C virus (HCV) infection within the liver.

28 Oct 2015

Watching too much TV increases risk of death

On average, 80% of American adults watch 3.5 hours of television per day and multiple observational studies have demonstrated a link between TV viewing and poorer health. In this new study published in the December issue of the American Journal of Preventive Medicine, investigators reported an association between increasing hours of television viewing per day and increasing risk of death from most of the major causes of death in the United States.

28 Oct 2015

Diabetic patients at increased risk for developing surgical site infections

Diabetic patients are at considerably increased risk for developing surgical site infections (SSIs) while undergoing most types of surgeries, compared to non-diabetic patients, according to a new study published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

28 Oct 2015

Australian researchers find a way to boost cross-protective capabilities of influenza A vaccine

Australian researchers have found a way to boost the effectiveness and cross-protective capabilities of an influenza A vaccine by adding a simple component. Published this week in mBio, an online open-access journal of the American Society for Microbiology, the research in mice could lead to better seasonal flu vaccines for humans, and also vaccines that could provide community protection in the early stages of an outbreak of a novel flu virus strain.

28 Oct 2015

Infections with Lone star ticks appear to be surging but deaths are not, new study reveals

A mild disease spread by the aggressive Lone star tick that is now colonizing large swaths of the United States is being mistaken for Rocky Mountain spotted fever, according to a new study from scientists at the U.S. Centers for Disease Control and Prevention.

28 Oct 2015

Sekisui Diagnostics launches new OSOM Flu, iFOB and hCG tests

Today, Sekisui Diagnostics announces the launch of three new rapid tests as additions to the OSOM portfolio. Providing accurate results with minimal hands on time, OSOM Ultra Flu A&B and OSOM Ultra hCG Combo complement the existing Flu and hCG product lines, while the OSOM iFOB provides a new diagnostic option for fecal occult blood testing.

27 Oct 2015

MedStar Washington Hospital Center's Ebola Response Team recognized with 2015 Patient Safety Award

MedStar Washington Hospital Center's Ebola Response Team has been honored with the 2015 Patient Safety Award from the District of Columbia Hospital Association. The award recognizes the team's outstanding efforts in its Ebola-related plans and training to care for potential or confirmed patients with the Ebola virus.

27 Oct 2015

New computer model predicts levels of HIV care engagement

A computer model developed by Johns Hopkins health care delivery specialists predicts that strengthening a handful of efforts to keep people with HIV in lifetime care, along with more rigorous testing, would potentially avert a projected 752,000 new HIV infections and 276,000 AIDS deaths in the United States alone over the next 20 years.

27 Oct 2015

Disease/Infection News

Researchers test effectiveness of commercially available mosquito repellents

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

New studies raise important questions about impact of statin therapy on effectiveness of flu vaccines

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

UAB researcher awarded NIH grant to study pathogenesis of thrombotic microangiopathy

Vasculitis Foundation named winner in Nonprofit Connect 2015 Philly Awards

Scientists identify key groups of bacteria responsible for majority of meningococcal cases in England, Wales

New paper device could rapidly and inexpensively assess hepatitis B, male infertility

Researchers report new way to help improve vaccines using molecules that direct the immune system

New broad-spectrum antibiotic can kill bacteria by punching holes in their membranes

Hiroshima University researchers report promising new avenue for treating hepatitis B

Researchers uncover genes that can suppress HCV infection within the liver

Watching too much TV increases risk of death

Diabetic patients at increased risk for developing surgical site infections

Australian researchers find a way to boost cross-protective capabilities of influenza A vaccine

Infections with Lone star ticks appear to be surging but deaths are not, new study reveals

Sekisui Diagnostics launches new OSOM Flu, iFOB and hCG tests

MedStar Washington Hospital Center's Ebola Response Team recognized with 2015 Patient Safety Award

New computer model predicts levels of HIV care engagement

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News